Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 1;28(4):307-313.
doi: 10.1097/MCP.0000000000000882.

The influence of age and sex in sarcoidosis

Arindam Singha  1 , Marina Kirkland  2 , Wonder Drake  2 , Elliott D Crouser  1
Affiliations
Review

The influence of age and sex in sarcoidosis

Arindam Singha et al. Curr Opin Pulm Med. .

Abstract

Purpose of review: This review aims to describe how the clinical manifestations of sarcoidosis may be shaped by the effects of sex hormones and by age dependent changes in immune functions and physiology This review is intended to highlight the need to consider the effects of sex and sex in future studies of sarcoidosis.

Recent findings: The clinical manifestations of sarcoidosis differ based on sex and gender There is emerging evidence that female and male hormones and X-linked genes are important determinants of immune responses to environmental antigens, which has important implications for granuloma formation in the context of sarcoidosis Furthermore, sex hormone levels predictably change throughout adolescence and adulthood, and this occurs in parallel with the onset immune senescence and changes in physiology with advanced age.

Summary: Recent studies indicate that sex and age are important variables shaping the immune response of humans to environmental antigens We posit herein that sex and age are important determinants of sarcoidosis clinical phenotypes Many gaps in our understanding of the roles played by sex and gender in sarcoidosis, and these need to be considered in future studies.

PubMed Disclaimer

References

    1. Arkema EV, Elizabeth V, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 2018; 9:227–240.
    1. Cozier YC, Berman JS, Palmer JR, et al. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest 2011; 139:144–150.
    1. Bert A, Gilbert T, Cottin V, et al. Sarcoidosis diagnosed in the elderly: a case-control study. QJM 2021; 114:238–245.
    1. Varron L, Cottin V, Schott AM, et al. Late-onset sarcoidosis: a comparative study. Medicine (Baltimore) 2012; 91:137–143.
    1. Brito-Zerón P, Sellarés J, Bosch X, et al. Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences. Clin Exp Rheumatol 2016; 34:380–388.

Publication types